<code id='7ACB77B7BA'></code><style id='7ACB77B7BA'></style>
    • <acronym id='7ACB77B7BA'></acronym>
      <center id='7ACB77B7BA'><center id='7ACB77B7BA'><tfoot id='7ACB77B7BA'></tfoot></center><abbr id='7ACB77B7BA'><dir id='7ACB77B7BA'><tfoot id='7ACB77B7BA'></tfoot><noframes id='7ACB77B7BA'>

    • <optgroup id='7ACB77B7BA'><strike id='7ACB77B7BA'><sup id='7ACB77B7BA'></sup></strike><code id='7ACB77B7BA'></code></optgroup>
        1. <b id='7ACB77B7BA'><label id='7ACB77B7BA'><select id='7ACB77B7BA'><dt id='7ACB77B7BA'><span id='7ACB77B7BA'></span></dt></select></label></b><u id='7ACB77B7BA'></u>
          <i id='7ACB77B7BA'><strike id='7ACB77B7BA'><tt id='7ACB77B7BA'><pre id='7ACB77B7BA'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:79

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Boston Scientific acquires urology company Axonics for $3.7 billion
          Boston Scientific acquires urology company Axonics for $3.7 billion

          BostonScientificisgrowingitsurologyportfoliowiththeAxonicsacquisition.StevenSenne/APBostonScientific

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          American taxpayers paid $1.8 trillion in health care costs in 2022

          AdobeAmericantaxpayersfootedthebillforatleast$1.8trillioninfederalandstatehealthcareexpendituresin20